Protecting young lungs: RSV prevention in infants

A/Prof Daryl Cheng

writer

A/Prof Daryl Cheng

Consultant Paediatrician; Medical Executive Leader; Clinical Informatician, The Royal Children's Hospital Melbourne; Head, Paediatrics, Cabrini Health; Chief Medical Officer, Magentus

Claim CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

1 hours

These are activities that use your work data to ensure quality results.

EA
0.5 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 minutes

These are activities that require reflection on feedback about your work.

MO
1 minutes

These are activities that use your work data to ensure quality results.

A/Prof Daryl Cheng

While respiratory syncytial virus (RSV) occurs across all age groups, it disproportionately affects young children, particularly infants in the first year of life – and especially those aged under six months. RSV prevention during early infancy is therefore a major public health priority.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

  1. Nair H, et al. Lancet 2010;375:1545–55
  2. Shi T, et al. Lancet 2017;390:946–58
  3. Piedimonte G, et al. Pediatr Rev 2014;35:519–30
  4. Johnson EK, et al. Popul Health Metr 2021;19:31
  5. Evohealth 2023. https://www.evohealth.com.au/wp-content/uploads/2023/09/Time-to-Act-protecting-our-children-from-RSV-.pdf. Accessed July 6, 2026.
  6. National Centre for Immunisation Research and Surveillance Australia 2026. https://ncirs.org.au/maternal-rsv-vaccine-uptake-data/all-females-abrysvo-uptake-age-group. Accessed July 10, 2026.
  7. RESP-NET. Data last updated May 28, 2026. https://www.cdc.gov/resp-net/dashboard/.
  8. Patton ME, et al. Morb Mortal Wkly Rep 2025;74:273–81
  9. Zambrano LD, et al. Morb Mortal Wkly Rep 2025;74:580–88
  10. Pérez Marc G, et al. Lancet Infect Dis 2025;25:1044–54
  11. Razzini JL, et al. Lancet Reg Health Am 2025:52:101296
  12. McLachlan I, et al. Lancet Infect Dis 2026;26:362-73
  13. Razzini JL, et al. Lancet Infect Dis 2026;26:522–34
  14. Attaianese F, et al. J Infect 2025;91:106600
  15. Wadia U, et al. J Infect 2025;90:106466
  16. Australian Immunisation Handbook. https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/respiratory-syncytial-virus-rsv#recommendations. Accessed July 6, 2026.
  17. Bertin B, et al. Therapie 2023;78:279-92
  18. Harris E. JAMA 2024;331:1439
  19. Therapeutic Goods Administration. https://www.tga.gov.au/news/safety-updates/correct-administration-rsv-vaccine-and-antibody-products. Accessed July 7, 2026.
  20. AusVaxSafety 2025. https://ausvaxsafety.org.au/new-ausvaxsafety-data-confirms-abrysvo-rsv-vaccine-well-tolerated-during-pregnancy-adverse-events. Accessed July 7, 2026.
  21. AusVaxSafety 2026. https://ausvaxsafety.org.au/national-immunisation-program-schedule-vaccines/pregnant-people-rsv-schedule-point. Accessed July 7, 2026.
  22. National Centre for Immunisation Research and Surveillance Australia 2026. https://ncirs.org.au/vaccine-recommendations-pregnant-women-guide-health-professionals. Accessed July 7, 2026.
  23. National Centre for Immunisation Research and Surveillance Australia 2026. https://ncirs.org.au/respiratory-syntactical-virus-rsv-immunisation/state-and-territory-nirsevimab-beyfortus-infant. Accessed July 7, 2026.
  24. Melbourne Vaccine Education Centre. https://mvec.mcri.edu.au/references/respiratory-syncytial-virus-rsv/. Accessed July 6, 2026.
  25. Immunisation Foundation of Australia. https://www.ifa.org.au/uniteagainstrsv. Accessed July 7, 2026.

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Gary Wittert

Prof Gary Wittert

The Peptide Craze – What You Need to Know

Prof Andrew Sindone AM

Prof Andrew Sindone AM

Managing Acute Heart Failure After Discharge: A Practical Guide for GPs

A/Prof Gino Pecoraro OAM

A/Prof Gino Pecoraro OAM

Oral Contraceptives on the PBS – A Practical Guide for GPs

Dr Terri Foran

Dr Terri Foran

The Impact of PFAS & Other Endocrine Disrupting Chemicals on Fertility

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

A/Prof Daryl Cheng

writer

A/Prof Daryl Cheng

Consultant Paediatrician; Medical Executive Leader; Clinical Informatician, The Royal Children's Hospital Melbourne; Head, Paediatrics, Cabrini Health; Chief Medical Officer, Magentus

Test your knowledge

Recent articles

Latest GP poll

In the last twelve months, how many adverse outcomes have you encountered arising from pharmacy prescribing?

None

0%

1-2

0%

Three or more

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.